GL1X · GenesisL1 explorer

Research workbench

Engineering inhibitors highly selective for the S1 sites of SER190 trypsin-like serine protease drug targets

Analyse Engineering inhibitors highly selective for the S1 sites of SER190 trypsin-like… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1GJ7
Type
protein
Length
256 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Urokinase-type plasminogen activator
EC
3.4.21.73
UniProt
P00749
Ligands
132
Pockets
1 · best druggability 0.42

Structure

x-ray diffraction · 2 distinct chains · 10% helix, 38% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AUrokinase-type plasminogen activatorprotein100% helix, 0% strandP00749
BUrokinase-type plasminogen activator (EC 3.4.21.73)protein24611% helix, 39% strandP00749

Ligands and binding sites

  • 132 · 6-chloro-2-(2-hydroxy-biphenyl-3-yl)-1H-indole-5-carboxamidine · ligand · chains B
  • CIT · Citric acid · additive · 2 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11100.420.7727132

Interfaces

1 interface between chains.

  • A–B · 565 Ų buried · 7 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide (disulfide).

Compared structures

  • 1GJ7 · Engineering inhibitors highly selective for the S1 sites of SER190 trypsin-like serine… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.